Core Points - E Fund Management Co., Ltd. reduced its stake in Tiger Medical (03347) by 429,800 shares at a price of approximately HKD 42.78 per share, totaling around HKD 18.3864 million [1] - After the reduction, E Fund's remaining shareholding is 9.4681 million shares, representing a holding percentage of 7.69% [1]

Group 1 - E Fund Management Co., Ltd. reduced its stake in Tiger Medical (300347) by 42,980 shares at a price of HKD 42.779 per share, totaling approximately HKD 18.3864 million [1] - After the reduction, E Fund's latest holding is 9.4681 million shares, representing a holding percentage of 7.69% [1]

Core Viewpoint - The recent surge in the issuance of public funds, particularly the rapid fundraising of FOF products, indicates a recovery in market liquidity and investor sentiment, reflecting a strong trust in stable assets and skilled fund managers [2][3][6]. Group 1: Fund Issuance Trends - On October 23, Huatai-PineBridge Yingtai Stable 3-Month Holding FOF announced the early closure of its fundraising period on its first day, marking it as another "daylight fund" [1][3]. - Multiple funds have recently completed fundraising on their first day, showcasing a resurgence of "daylight funds" in the market [2][3]. - The early closure of funds like the China Europe Value Navigator Fund and Penghua Manufacturing Upgrade Fund indicates sustained investor enthusiasm, with the latter attracting over 2 billion yuan in just two days [3][4][5]. Group 2: Performance and Market Sentiment - The emergence of "daylight funds" reflects ample market liquidity and a rebound in investor risk appetite, as seen with the performance of several FOF products [6][7]. - The Morgan Yingyuan Stable 3-Month Holding FOF, launched on August 7, was the first public FOF to complete fundraising in one day since 2025, with a total initial scale of 27.52 billion yuan [6]. - High-performing FOFs have shown impressive returns this year, with notable examples including Guotai's Preferred Navigator Fund achieving a total return of 72.83% [6][7]. Group 3: Future Outlook - The current trend indicates that FOF products are moving away from a previous "wait-and-see" phase, with a new influx of funds focusing on stable asset allocation and multi-asset strategies [7]. - The combination of declining interest rates and an optimized asset allocation structure among residents suggests a promising future for FOF products [7].

Group 1 - The core point of the article highlights the recent performance of Founder Technology, which saw a 5.07% increase in stock price, reaching 11.19 CNY per share, with a trading volume of 1.758 billion CNY and a turnover rate of 3.88%, resulting in a total market capitalization of 47.823 billion CNY [1] - Founder Technology Group Co., Ltd. is based in Shanghai and was established on November 15, 1993, with its listing date on December 19, 1990. The company's main business involves the production and sale of PCB products, internet access services, and IT system integration and solutions. The revenue composition is 98.83% from product sales and 1.17% from service provision [1] Group 2 - From the perspective of major fund holdings, data shows that one fund under E Fund has a significant position in Founder Technology. The E Fund CSI 1000 Quantitative Enhancement A (017094) held 198,300 shares in the second quarter, accounting for 0.45% of the fund's net value, making it the third-largest holding. The estimated floating profit today is approximately 107,100 CNY [2] - The E Fund CSI 1000 Quantitative Enhancement A (017094) was established on April 25, 2023, with a current scale of 128 million CNY. Year-to-date returns are 36.49%, ranking 1129 out of 4218 in its category; the one-year return is 42.68%, ranking 718 out of 3875; and since inception, the return is 37.84% [2] - The fund managers, Yin Ming and Huang Jiansheng, have tenures of 4 years and 5 years respectively. During their management, Yin Ming's best fund return is 86.36%, while the worst is 1.61%. Huang Jiansheng's best return is 57.73%, and the worst is -17.99% [2]

Core Viewpoint - E Fund Management Co., Ltd. announced the suspension of subscription, redemption, and regular investment for its Global Allocation Mixed Securities Investment Fund (QDII) starting from October 29, 2025, due to the Hong Kong Stock Connect and Hong Kong Stock Exchange being non-trading days [1] Group 1 - The suspension will take effect on October 29, 2025, impacting the fund's subscription and redemption activities [1] - The announcement includes details about the affected sub-funds, specifically the E Fund Global Allocation Mixed (QDII) A and C classes [1] - The specific codes for the sub-funds are 019155 for class A and 019156 for class C [1]

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，10月24日易方达基金管理有限公司发布《易方达全球医药行业混合型发起式证券投资基 金2025年10月29日暂停申购、赎回及定期定额投资业务的公告》。公告中提示，为2025年10月29日为港 股通和香港证券交易所非交易日，自2025年10月29日起易方达全球医药行业混合型发起式证券投资基金 2025年10月29日暂停申购、赎回及定期定额投资业务，下属分级基金调整明细如下： | 分级基金简称 | 代码 | 是否暂停（大额）申购 (转入转出、赎回、定投) | 申购限额 转入限额 定投限额 (元) (元) (元) | | --- | --- | --- | --- | | | 008284 | 를 | | | 易方达全球医药行业混 | 019035 | 를 | | | 合(QDII)A | | | | | 易方达全球医药行业混 合(QDII)C | | | | ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，10月24日易方达基金管理有限公司发布《易方达标普全球高端消费品指数增强型证券投 资基金2025年10月29日暂停申购、赎回及定期定额投资业务的公告》。公告中提示，为2025年10月29日 为香港证券交易所非交易日，自2025年10月29日起易方达标普全球高端消费品指数增强型证券投资基金 2025年10月29日暂停申购、赎回及定期定额投资业务，下属分级基金调整明细如下： | 分级基金简称 | 代码 | 是否暂停（大额）申购 (转入转出、赎回、定投) | 申购限额 转入限额 定投限额 (元) (元) (元) | | --- | --- | --- | --- | | 易方达标普消费品指数 | 118002 | 를 | | | 増强 (QDII) A | | | | | 易方达标普消费品指数 | 005676 | 를 | | | 増強 (QDII) C | | | | ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 | 分级基金简称 | 代码 | 是否暂停（大额）申购 | 申购限额 转入限额 定投限额 | | | | --- | --- | --- | --- | --- | --- | | | | (转入转出、赎回、定投) | (元) | (元) | (元) | | 易方达倪和稳 健债券A | 018898 | 를 | | | | | 易方达倪和稳 健债券C | 018899 | 문 | | | | 证券之星消息，10月24日易方达基金管理有限公司发布《易方达悦和稳健债券型证券投资基金2025年10 月29日暂停申购、赎回、转换及定期定额投资业务的公告》。公告中提示，为2025年10月29日为港股通 非交易日，自2025年10月29日起易方达悦和稳健债券型证券投资基金2025年10月29日暂停申购、赎回、 转换及定期定额投资业务，下属分级基金调整明细如下： ...

Core Viewpoint - Beijing Junzheng's stock price increased by 5% to 87.54 CNY per share, with a trading volume of 721 million CNY and a turnover rate of 1.98%, resulting in a total market capitalization of 42.242 billion CNY [1] Company Overview - Beijing Junzheng Integrated Circuit Co., Ltd. was established on July 15, 2005, and listed on May 31, 2011. The company is located in Haidian District, Beijing, and specializes in the research and sales of ASIC chip products, including microprocessor chips and smart video chips, as well as storage and analog chips [1] - The revenue composition of the company's main business includes: storage chips 61.56%, computing chips 26.87%, analog and interconnect chips 10.84%, and others 0.53% [1] Shareholder Information - E Fund's Chuangye ETF (159915) is among the top ten circulating shareholders of Beijing Junzheng, having increased its holdings by 156,000 shares in the second quarter, totaling 7.9885 million shares, which accounts for 1.9% of the circulating shares. The estimated floating profit today is approximately 33.3121 million CNY [2] - The E Fund Chuangye ETF was established on September 20, 2011, with a latest scale of 85.537 billion CNY. Year-to-date returns are 44.76%, ranking 618 out of 4218 in its category; the one-year return is 40.48%, ranking 824 out of 3875; and since inception, the return is 248.4% [2] - The fund managers, Cheng Xi and Liu Shurong, have tenures of 9 years and 8 years respectively, with total fund assets of 195.312 billion CNY and 112.299 billion CNY. Their best and worst fund returns during their tenures are 131.04%/-67.89% and 194.12%/-48.01% respectively [2]

Core Viewpoint - The announcement informs investors that certain funds managed by E Fund Management Co., Ltd. will suspend subscription, redemption, conversion, and regular investment services on October 29, 2025, due to the Hong Kong Stock Connect non-trading day and holidays in major overseas investment markets, with services resuming on October 30, 2025 [1][5][6]. Group 1: Fund Suspension Details - The suspension applies to multiple funds, including the E Fund Global Pharmaceutical Industry Mixed Fund and the E Fund Asian Select Equity Fund, affecting all share classes of these funds [5][6]. - Specific funds listed in the announcement will not allow subscription, redemption, conversion, or regular investment services on the specified date, with a detailed list provided in the attachment [1][2]. Group 2: Large Subscription Limit Adjustments - The E Fund Oil Securities Investment Fund (QDII) A Class RMB shares will have a new limit for large subscriptions, set at a maximum of 20 yuan per day per account across all sales channels, effective from October 24, 2025 [3]. - If a single subscription exceeds 20 yuan, only the first 20 yuan will be confirmed, and any excess will be rejected [3]. Group 3: Investor Information - Investors can obtain further information through the company's website or customer service hotline [2][5][6]. - The company will adjust and announce any changes to the suspension schedule if there are alterations in the Hong Kong Stock Connect non-trading day or overseas market holiday arrangements [1][5][6].